Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma.
Ghadjar P, Schreiber-Facklam H, Gräter R, Evers C, Simcock M, Geretschläger A, Blumstein NM, Zbären P, Zimmer Y, Wilkens L, Aebersold DM. Ghadjar P, et al. Among authors: simcock m. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1127-32. doi: 10.1016/j.ijrobp.2009.03.065. Epub 2009 Aug 3. Int J Radiat Oncol Biol Phys. 2010. PMID: 19647955
Incidence of small lymph node metastases with evidence of extracapsular extension: clinical implications in patients with head and neck squamous cell carcinoma.
Ghadjar P, Simcock M, Schreiber-Facklam H, Zimmer Y, Gräter R, Evers C, Arnold A, Wilkens L, Aebersold DM. Ghadjar P, et al. Among authors: simcock m. Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1366-72. doi: 10.1016/j.ijrobp.2009.09.043. Epub 2010 Mar 16. Int J Radiat Oncol Biol Phys. 2010. PMID: 20231070
Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
Ghadjar P, Simcock M, Studer G, Allal AS, Ozsahin M, Bernier J, Töpfer M, Zimmermann F, Betz M, Glanzmann C, Aebersold DM; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Among authors: simcock m. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):524-31. doi: 10.1016/j.ijrobp.2010.11.067. Epub 2011 Feb 16. Int J Radiat Oncol Biol Phys. 2012. PMID: 21300466 Clinical Trial.
High dose-rate versus low dose-rate brachytherapy for lip cancer.
Ghadjar P, Bojaxhiu B, Simcock M, Terribilini D, Isaak B, Gut P, Wolfensberger P, Brömme JO, Geretschläger A, Behrensmeier F, Pica A, Aebersold DM. Ghadjar P, et al. Among authors: simcock m. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1205-12. doi: 10.1016/j.ijrobp.2011.09.038. Epub 2011 Nov 16. Int J Radiat Oncol Biol Phys. 2012. PMID: 22099044
Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94).
Ghadjar P, Simcock M, Zimmermann F, Betz M, Bodis S, Bernier J, Studer G, Aebersold DM; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Among authors: simcock m. Radiother Oncol. 2012 Aug;104(2):213-8. doi: 10.1016/j.radonc.2012.05.004. Epub 2012 Jun 21. Radiother Oncol. 2012. PMID: 22726581 Clinical Trial.
Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07).
Zaman K, Thürlimann B, Huober J, Schönenberger A, Pagani O, Lüthi J, Simcock M, Giobbie-Hurder A, Berthod G, Genton C, Brauchli P, Aebi S; Swiss Group for Clinical Cancer Research (SAKK). Zaman K, et al. Among authors: simcock m. Ann Oncol. 2012 Jun;23(6):1474-81. doi: 10.1093/annonc/mdr448. Epub 2011 Oct 14. Ann Oncol. 2012. PMID: 22003243 Free article.
47 results